Drager Medizintechnik GmbH and Masimo Corporation

Announce Pulse Oximetry Purchasing and Licensing Agreement IRVINE, Calif. (PROTEXT) - Drager Medizintechnik GmbH (Lübek, Germany) and Masimo Corporation (Irvine, CA) announced a purchasing and licensing agreement under which Drager will integrate Masimo Signal Extraction pulse oximetry technology into its future patient monitors which incorporate pulse oximetry. Drager Medizintechnik GmbH is a leading manufacturer of medical equipment worldwide. Drager has earned a reputation of excellence in both product design and customer support. Masimo Signal Extraction pulse oximetry is the only technology clinically proven accurate during patient motion and low perfusion. Numerous published studies have shown a virtual elimination of false alarms without sacrificing the ability to detect true alarms with Masimo Signal Extraction pulse oximetry, as compared with the other leading pulse oximetry systems. "During Drager's long history, we have made one commitment to our customers, and that is to provide them with the best technology possible," stated Frank Rochlitzer, President of Drager Medizintechnik GmbH. "We spent considerable time evaluating the performance of Masimo SET pulse oximetry and concluded that Masimo SET pulse oximetry would be an ideal choice for our future monitors and our customers." Joe E. Kiani, President and Chief Executive Officer of Masimo Corporation, stated, "Drager is widely recognized as one of the premier providers of medical equipment in the world. Just about everything they sell is considered best in its class and most people in the industry recognize Drager as being synonymous with quality. After working with Drager, I now understand how they achieved such a reputation. Their team is as solid a group of professionals that we have had the pleasure to work with. We are delighted to have Drager as a partner." Masimo Corporation is a privately-held medical technology company that designs, develops and licenses advanced medical signal processing and sensor technology for the noninvasive monitoring of vital physiological parameters. Masimo has created a fundamentally unique method to measure arterial oxygen saturation and pulse rate. Masimo Signal Extraction pulse oximetry is the only technology clinically proven accurate during patient motion and low perfusion. Masimo has licensed its Signal Extraction pulse oximetry OEM boards and proprietary single patient adhesive and reusable sensors to more than 25 international patient monitoring system providers. Masimo is located in Irvine, California. ots Original Text Service: Masimo Corporation Internet: http://www.newsaktuell.de Contact: Brad Langdale of Masimo Corporation, 949-253-6404 Web site: http://www.masimo.com Subscribers please note that material bearing the slug "PROTEXT" is not part of CTK's news service and is not to be published under the "CTK" slug. Protext is a commercial service providing distribution of press releases from clients, who are identified in the text of Protext reports and who bear full responsibility for their contents. PROTEXT